By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Green Cross 



Osaka      Japan
Phone: N/A Fax:


SEARCH JOBS








Company News
President Of Leading South Korean Biopharmaceutical Company Green Cross Joins Stemedica Cell Technologies, Inc.'s Board Of Directors 4/22/2014 2:35:58 PM
Aquavit and Green Cross Sign Strategic Collaboration MOU on IBX-001 Product Development and Commercialization in Asia 8/9/2012 9:58:55 AM
Green Cross Gains Market Approval With the World's 2nd Orphan Drug for Hunter Syndrome in South Korea 1/26/2012 9:42:03 AM
Jennerex and Green Cross Announce Publication of Positive Clinical Data of JX-594 in Combination With Sorafenib in Advanced Liver Cancer 4/21/2011 7:54:56 AM
Biocryst Pharmaceuticals (BCRX) Partner Green Cross Receives Marketing & Manufacturing Approval for Peramivir in South Korea 8/16/2010 8:00:29 AM
Biocryst Pharmaceuticals (BCRX)'s Partner Green Cross Files for Peramivir Regulatory Approval in South Korea 1/8/2010 9:07:33 AM
Abraxis BioScience, Inc. Announces Agreement with Green Cross for the Commercialization of ABRAXANE in Korea 11/28/2007 9:57:10 AM
OctoPlus Grants Green Cross Exclusive Korean License To OP-145 For Chronic Middle Ear Infection 11/22/2006 10:53:16 AM
Biocryst Pharmaceuticals (BCRX) And Green Cross Enter Agreement To Develop And Commercialize Peramivir In South Korea 6/14/2006 10:32:25 AM
SanguiBioTech GmbH And Green Cross Plan To Evaluate Options For A Possible Cooperation10/19/2005 5:12:57 PM
12
//-->